Medifast, Inc.
MED
$12.36
$0.534.48%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -96.61% | -87.60% | -110.33% | -97.90% | -93.89% |
| Total Depreciation and Amortization | 79.82% | 74.86% | 63.63% | 67.06% | 1.31% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -123.02% | -121.95% | -5.60% | -31.13% | 189.34% |
| Change in Net Operating Assets | 40.56% | -74.63% | -106.20% | -148.06% | -131.74% |
| Cash from Operations | -81.99% | -93.17% | -77.33% | -83.42% | -78.85% |
| Capital Expenditure | -7.08% | -2.69% | -14.91% | -14.98% | 58.12% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -35.51% | 94.05% | 66.37% | 65.06% | 73.86% |
| Cash from Investing | -25.75% | 84.14% | 58.19% | 56.56% | 69.99% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | -100.00% | -100.00% | -80.85% | 13.33% |
| Repurchase of Common Stock | 56.09% | 60.86% | 58.68% | 87.99% | 93.67% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 98.96% | 99.47% | 99.64% | 99.02% | 74.38% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 97.09% | 98.49% | 98.94% | 98.10% | 77.48% |
| Foreign Exchange rate Adjustments | 100.00% | 103.13% | 148.48% | 165.28% | 36.97% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -717.41% | 83.95% | 78.10% | -152.04% | -94.06% |